DePuy Synthes Accelerates Recovery Outlook for 2020

DePuy Synthes' logo

DePuy Synthes reported 2Q20 orthopedic revenue of USD $1,451.7 million, -34.7% vs. 2Q19. While elective procedure restrictions continued to negatively impact the company, second-quarter performance exceeded expectations. Johnson & Johnson revised its outlook for the remainder of 2020. For its Medical Devices business, company...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us